Patent classifications
C
C07
C07D
211/00
C07D211/04
C07D211/80
C07D211/84
C07D211/84
Means and methods for improving anti-tumoral efficacy of transmembrane channel protein blockers
12594257
·
2026-04-07
·
·
This invention is related to an anti-tumoral composition for the treatment of neoplastic pathologies of malignant kind, and for the treatment of eg7 thymic lymphoma. Said composition comprises a TMEM176A/B inhibitor formulated in nanoparticles. This invention is also related to a method of treating neoplastic pathologies of malignant kind. Said method comprises the steps of administering to a subject a TMEM176A/B inhibitor formulated in nanoparticles.